Nivolumab Is Safe and Effective in Elderly Patients With Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety Data in Elderly Patients With Metastatic Renal Cell Carcinoma Included in the Nivolumab Expanded Access Program (EAP) in Italy
PLoS ONE 2018 Jul 01;13(7)e0199642, MG Vitale, S Scagliarini, L Galli, S Pignata, G Lo Re, A Berruti, C Defferrari, M Spada, C Masini, D Santini, L Ciuffreda, EM Ruggeri, C Bengala, L Livi, D Fagnani, A Bonetti, L Giustini, A Hamzaj, G Procopio, C Caserta, R SabbatiniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.